Variant report
Variant | nsv967258 |
---|---|
Chromosome Location | chr3:94286134-94300566 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:94210684..94213221-chr3:94300303..94302225,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549319224 | chr3:94286181-94286182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs186815778 | chr3:94286205-94286206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531026377 | chr3:94286222-94286223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs140732235 | chr3:94286223-94286224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs567498051 | chr3:94286232-94286233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs529000434 | chr3:94286275-94286276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs375437978 | chr3:94286405-94286406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs116382039 | chr3:94286441-94286442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs150094730 | chr3:94286473-94286474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs1948182 | chr3:94286491-94286492 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs557784833 | chr3:94286503-94286504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs571553274 | chr3:94286513-94286514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs188739405 | chr3:94286526-94286527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557241001 | chr3:94286535-94286536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs573873886 | chr3:94286544-94286545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181165582 | chr3:94286562-94286563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs150372695 | chr3:94286588-94286589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185429113 | chr3:94286608-94286609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs9818503 | chr3:94286709-94286710 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs115028226 | chr3:94286717-94286718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs145451548 | chr3:94286730-94286731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs189805267 | chr3:94286804-94286805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs544499868 | chr3:94286814-94286815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs140308981 | chr3:94286832-94286833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs530191154 | chr3:94286838-94286839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs183554410 | chr3:94286874-94286875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs145340424 | chr3:94286907-94286908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs528160729 | chr3:94286937-94286938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs551385026 | chr3:94286966-94286967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs571154410 | chr3:94286972-94286973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs187189628 | chr3:94286988-94286989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs9870987 | chr3:94286997-94286998 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs192123188 | chr3:94287000-94287001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs536420692 | chr3:94287029-94287030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs553516371 | chr3:94287050-94287051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs183485588 | chr3:94287058-94287059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs542003054 | chr3:94287067-94287068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs188540506 | chr3:94287095-94287096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs138965326 | chr3:94287096-94287097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs142101662 | chr3:94287138-94287139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs112309102 | chr3:94287155-94287156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs191789562 | chr3:94287188-94287189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs561198685 | chr3:94287198-94287199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs182468550 | chr3:94287254-94287255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs540460714 | chr3:94287287-94287288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs371000427 | chr3:94287331-94287332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs186803448 | chr3:94287347-94287348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs528238583 | chr3:94287414-94287415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs551182195 | chr3:94287434-94287435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs564909250 | chr3:94287439-94287440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Epilepsy | 21858020 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:94285800-94286800 | Weak transcription | Liver | Liver |
2 | chr3:94286800-94287600 | Enhancers | Liver | Liver |
3 | chr3:94287600-94292000 | Weak transcription | Liver | Liver |
4 | chr3:94291600-94292600 | Enhancers | Adipose Nuclei | Adipose |
5 | chr3:94292000-94293000 | Enhancers | Liver | Liver |
6 | chr3:94296000-94297400 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr3:94297400-94297600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr3:94297600-94298000 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr3:94298000-94298400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr3:94298000-94298800 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr3:94298800-94299000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr3:94299000-94299800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr3:94299800-94300200 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |